Medications

The drugs don't work

(Medical Xpress)—Drugs that do not represent value for money or are medically unproven may be increasingly reaching one of Europe's largest pharmaceutical markets, according to research undertaken by Cambridge sociologist ...

Medications

More biosimilars marketed in Germany, Switzerland than U.S.

More biosimilars have been marketed in Germany and Switzerland than in the United States, but uptake has increased over time in all countries, according to a study published online Dec. 2 in JAMA Network Open.

Psychology & Psychiatry

Sharp decline in mental health for young Australians

COVID-19 is continuing to lead to worsening mental health outcomes for young Australians, with the highest levels of psychological distress for 18- to 24-year-olds observed this year, new analysis from The Australian National ...

Cardiology

Clear link between income and survival after cardiac surgery

The higher a patient's income, the better are his or her chances of surviving cardiac surgery in both the short and long term. This is the finding of a new registry study by researchers from Sweden's Karolinska Institutet ...

Alzheimer's disease & dementia

FDA wants to relax approval process for Alzheimer's drugs

(HealthDay)—In an effort to quickly develop drugs that could prevent or slow Alzheimer's, the U.S. Food and Drug Administration said it plans to relax the approval process for experimental medications for the memory-robbing ...

Medications

Investigation questions motives behind post-marketing studies

An investigation published by the BMJ today raises concern about the motives behind post-marketing studies of new treatments for diabetes and calls for better regulation to ensure "a proper balance" between the commercial ...

page 1 from 2